These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12409084)

  • 1. No rules without exception: a long-term complete remission observed in a study using a LH-RH agonist in platinum-refractory ovarian cancer.
    Paskeviciute L; Roed H; Engelholm A
    Eur J Cancer; 2002 Nov; 38 Suppl 6():S73. PubMed ID: 12409084
    [No Abstract]   [Full Text] [Related]  

  • 2. No rules without exception: long-term complete remission observed in a study using a LH-RH agonist in platinum-refractory ovarian cancer.
    Paskeviciute L; Roed H; Engelholm S
    Gynecol Oncol; 2002 Sep; 86(3):297-301. PubMed ID: 12217751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term suppression of testosterone after treatment with a gonadotropin-releasing hormone agonist in a woman with a presumed testosterone secreting ovarian tumor.
    Barnes RB; Ehrmann DA
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1746-8. PubMed ID: 9177374
    [No Abstract]   [Full Text] [Related]  

  • 4. Leuprolide acetate as a salvage-therapy in relapsed epithelial ovarian cancer.
    Marinaccio M; D'Addario V; Serratì A; Pinto V; Cagnazzo G
    Eur J Gynaecol Oncol; 1996; 17(4):286-8. PubMed ID: 8856307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of AEZS-108 (INN: zoptarelin doxorubicin acetate) an LHRH agonist linked to doxorubicin in women with platinum refractory or resistant ovarian cancer expressing LHRH receptors: a multicenter phase II trial of the ago-study group (AGO GYN 5).
    Emons G; Gorchev G; Sehouli J; Wimberger P; Stähle A; Hanker L; Hilpert F; Sindermann H; Gründker C; Harter P
    Gynecol Oncol; 2014 Jun; 133(3):427-32. PubMed ID: 24713545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics, effects, side effects of the LH-RH agonist].
    Miyanaga N; Akaza H
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():177-81. PubMed ID: 12599567
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of high risk Sertoli-Leydig cell tumors of the ovary using a gonadotropin releasing hormone (GnRH) analog.
    Lashkari HP; Nash R; Albanese A; Okoye B; Millar R; Pritchard-Jones K
    Pediatr Blood Cancer; 2013 Jun; 60(6):E16-8. PubMed ID: 23193086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resected atypical meningioma relapsed to anaplastic meningioma during luteinizing hormone-releasing hormone agonist therapy.
    Nicosia L; Bucpapaj R; Barresi V; Damante R; Napoli G; Ghimenton C; Giaj-Levra N; Cancedda M; Flaminio S; Figlia V; Alongi F
    Neurochirurgie; 2021 Apr; 67(2):193-197. PubMed ID: 33190809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure to achieve castrate levels of testosterone during luteinizing hormone releasing hormone agonist therapy: the case for monitoring serum testosterone and a treatment decision algorithm.
    Oefelein MG; Cornum R
    J Urol; 2000 Sep; 164(3 Pt 1):726-9. PubMed ID: 10953134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gn-RH antagonist possible response, after Gn-RH agonist failure in a man with metastatic prostate cancer.
    Rocco B; Ferrari M; Scardino E; Matei DV; Verweij F; Varela R; De Cobelli O
    Anticancer Res; 2005; 25(1B):577-8. PubMed ID: 15816630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of gonadotropin-releasing hormone agonists on uterine leiomyomas.
    Cramer SF
    Arch Pathol Lab Med; 1998 Dec; 122(12):1045-6. PubMed ID: 9870847
    [No Abstract]   [Full Text] [Related]  

  • 12. Encouraging response of an advanced steroid-cell tumor to GnRH agonist therapy.
    Brewer CA; Shevlin D
    Obstet Gynecol; 1998 Oct; 92(4 Pt 2):661-3. PubMed ID: 9764654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GnRH agonist therapy in a patient with recurrent ovarian granulosa cell tumors.
    Kim HJ; Lee SC; Bae SB; Kwon KW; Kim CK; Lee NS; Lee KT; Won JH; Hong DS; Park HS
    J Korean Med Sci; 2009 Jun; 24(3):535-8. PubMed ID: 19543423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary and salvage therapy with LH-RH analogues in ovarian cancer.
    Emons G; Schulz KD
    Recent Results Cancer Res; 2000; 153():83-94. PubMed ID: 10626291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary medical management of recurrent aggressive angiomyxoma of the vulva with a gonadotropin-releasing hormone agonist.
    Fine BA; Munoz AK; Litz CE; Gershenson DM
    Gynecol Oncol; 2001 Apr; 81(1):120-2. PubMed ID: 11277663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotropin-releasing hormone-agonist as a neoadjuvant therapy for Sertoli-Leydig cell tumors of the ovary.
    Chao HT; Wang PH; Lin HD
    Int J Gynaecol Obstet; 1999 Aug; 66(2):189-90. PubMed ID: 10468350
    [No Abstract]   [Full Text] [Related]  

  • 17. Second-line therapy of advanced ovarian cancer with GnRH analogs.
    Balbi G; Piano LD; Cardone A; Cirelli G
    Int J Gynecol Cancer; 2004; 14(5):799-803. PubMed ID: 15361187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective determination of the hormonal response after cessation of luteinizing hormone-releasing hormone agonist treatment in patients with prostate cancer.
    Hall MC; Fritzsch RJ; Sagalowsky AI; Ahrens A; Petty B; Roehrborn CG
    Urology; 1999 May; 53(5):898-902; discussion 902-3. PubMed ID: 10223480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness of LH-RH agonist for bone metastases of breast cancer--report of a case].
    Kudoh S; Kawamura H; Suzuki Y; Matsuzaki M; Nishina M; Tsukamoto M
    Gan To Kagaku Ryoho; 1996 May; 23(6):787-90. PubMed ID: 8645031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leuprolide acetate in advanced ovarian serous tumor of low malignant potential. A case report.
    Tresukosol D; Kudelka AP; Edwards CL; Silva EG; Kanojia M; Kavanagh JJ
    J Reprod Med; 1996 May; 41(5):363-6. PubMed ID: 8725765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.